Statin use is not associated with reduced risk of skin cancer: a meta-analysis
- PMID: 24366301
- PMCID: PMC3915126
- DOI: 10.1038/bjc.2013.762
Statin use is not associated with reduced risk of skin cancer: a meta-analysis
Abstract
Background: There is contradictory evidence about the association between statin and skin cancer.
Methods: Literature search in PubMed and Web of Science was undertaken up to June 2013. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were calculated.
Result: A total of 21 articles with 29 studies were identified. No association was found between statin and skin cancer among neither melanoma (RR, 0.94; 95% CI, 0.85-1.04) nor non-melanoma skin cancer (RR, 1.03; 95% CI, 0.90-1.19).
Conclusion: Our meta-analysis does not support a potential role of statin use in the prevention of skin cancer.
References
-
- Bonovas S, Nikolopoulos G, Filioussi K, Peponi E, Bagos P, Sitaras NM. Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. Eur J Epidemiol. 2010;25 (1:29–35. - PubMed
-
- Clendening JW, Penn LZ. Targeting tumor cell metabolism with statins. Oncogene. 2012;31 (48:4967–4978. - PubMed
-
- Coimbra M, Banciu M, Fens MH, de Smet L, Cabaj M, Metselaar JM, Storm G, Schiffelers RM. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. J Control Release. 2010;148 (3:303–310. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
